CARLOS
SOLANO VERCET

CATEDRÁTICO/A DE UNIVERSIDAD

Foto de CARLOS

Foto de Cristina

Cristina
Ferreras Puente

Publicacions en què col·labora amb Cristina Ferreras Puente (6)

2024

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cytotherapy, Vol. 26, Núm. 1, pp. 25-35

2023

Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14

2022

Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy
Immunology, Vol. 165, Núm. 2, pp. 234-249

2021

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
Frontiers in Cell and Developmental Biology, Vol. 9